AMP President Updates CDC Committee on H1N1 Testing
Dr. Jan Nowak, President of the Association for Molecular Pathology presented public comments at the Clinical Laboratory Improvement Advisory Committee meeting.
Read MoreMonth: September 2009
DxS Enters Collaboration With Bristol-Myers, ImClone
DxS, a personalised medicine company, has entered into a collaboration agreement with Bristol-Myers Squibb Company (NYSE: BMY) and ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company (NYSE: LLY), to further develop a K-RAS companion diagnostic for ERBITUX (cetuximab) in the United States and Canada.
Read MoreDr. David Okrongly Appointed CEO of Quanterix Corporation
Quanterix Corporation announced that David Okrongly, Ph.D. has been appointed Chief Executive Officer and a member of the company’s Board of Directors.
Read More
The Codes, They Are A-Changin’
What laboratories should be doing now to prepare for the conversions to ICD-10 and X12 5010.
Read MoreMultiGEN Diagnostics Launches DNA Sequencing Technology
San Diego-based MultiGEN Diagnostics Inc. has launched a novel multi-target DNA sequencing technology (MultiGEN) for a wide range of clinical testing in molecular diagnostics.
Read More